On Monday, Ascendis Pharma A/S ADR (NASDAQ: ASND) was 1.19% up from the session before settling in for the closing price of $126.97. A 52-week range for ASND has been $85.29 – $161.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 182.00% over the last five years. When this article was written, the company’s average yearly earnings per share was at 33.18%. With a float of $55.88 million, this company’s outstanding shares have now reached $56.61 million.
Ascendis Pharma A/S ADR (ASND) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Ascendis Pharma A/S ADR stocks. The insider ownership of Ascendis Pharma A/S ADR is 1.30%, while institutional ownership is 107.27%.
Ascendis Pharma A/S ADR (ASND) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 33.18% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -1.02% during the next five years compared to -19.87% drop over the previous five years of trading.
Ascendis Pharma A/S ADR (NASDAQ: ASND) Trading Performance Indicators
You can see what Ascendis Pharma A/S ADR (ASND) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 20.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -9.64, a number that is poised to hit -1.63 in the next quarter and is forecasted to reach -1.78 in one year’s time.
Technical Analysis of Ascendis Pharma A/S ADR (ASND)
Analysing the last 5-days average volume posted by the [Ascendis Pharma A/S ADR, ASND], we can find that recorded value of 0.48 million was better than the volume posted last year of 0.37 million. As of the previous 9 days, the stock’s Stochastic %D was 37.52%. Additionally, its Average True Range was 5.42.
During the past 100 days, Ascendis Pharma A/S ADR’s (ASND) raw stochastic average was set at 29.48%, which indicates a significant decrease from 42.52% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 31.23% in the past 14 days, which was lower than the 33.55% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $132.95, while its 200-day Moving Average is $130.12. Now, the first resistance to watch is $136.12. This is followed by the second major resistance level at $143.76. The third major resistance level sits at $147.82. If the price goes on to break the first support level at $124.42, it is likely to go to the next support level at $120.36. Now, if the price goes above the second support level, the third support stands at $112.72.
Ascendis Pharma A/S ADR (NASDAQ: ASND) Key Stats
There are 58,231K outstanding shares of the company, which has a market capitalization of 7.27 billion. As of now, sales total 288,670 K while income totals -521,070 K. Its latest quarter income was 104,110 K while its last quarter net income were -142,260 K.
